CN100389752C
(zh)
*
|
1978-04-21 |
2008-05-28 |
莱博法姆公司 |
控释组合物
|
US8071128B2
(en)
*
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
DE10220470A1
(de)
*
|
2002-04-30 |
2003-11-20 |
Roehm Gmbh |
ph-sensitives Polymer
|
DE19961334A1
(de)
*
|
1999-12-17 |
2001-06-21 |
Roehm Gmbh |
Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
|
DE10011447A1
(de)
*
|
2000-03-10 |
2001-09-20 |
Roehm Gmbh |
Dispersion mit nichtionischem Emulgator
|
CA2359812C
(en)
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
PL201766B1
(pl)
*
|
2001-01-31 |
2009-05-29 |
Roehm Gmbh |
Wielocząsteczkowa postać leku zawierająca przynajmniej dwa typy granulek powlekanych w odmienny sposób oraz jej zastosowanie
|
DE10127134A1
(de)
*
|
2001-06-05 |
2002-12-12 |
Roehm Gmbh |
verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
|
US20030124196A1
(en)
*
|
2001-08-22 |
2003-07-03 |
Susan Weinbach |
Pulsatile release compositions and methods for enhanced intestinal drug absorption
|
US9358214B2
(en)
*
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
DE10149674A1
(de)
*
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
DE10208335A1
(de)
*
|
2002-02-27 |
2003-09-04 |
Roehm Gmbh |
Arzneiform und Verfahren zu ihrer Herstellung
|
DE10214002A1
(de)
*
|
2002-03-27 |
2003-10-09 |
Roehm Gmbh |
Pharmazeutische Formulierung für den Wirkstoff Budesonid
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
EP2596792A1
(en)
*
|
2002-10-16 |
2013-05-29 |
Takeda Pharmaceutical Company Limited |
Stable solid preparations
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
BR0315657A
(pt)
*
|
2002-10-25 |
2005-09-13 |
Labopharm Inc |
Formulação de dosagem sólida, comprimido para liberação controlada, método de fabricar uma medicação de liberação controlada, composição farmacêutica e uso de uma composição
|
DE10250543A1
(de)
*
|
2002-10-29 |
2004-05-19 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform
|
JP4494712B2
(ja)
*
|
2002-11-12 |
2010-06-30 |
大日本住友製薬株式会社 |
マルチプルユニット型徐放性製剤
|
DE10260920A1
(de)
*
|
2002-12-20 |
2004-07-01 |
Röhm GmbH & Co. KG |
Verfahren zur Herstellung von Arnzeiformen oder Nahrungsergänzungsmitteln mit pigmentierten Polymerüberzügen
|
US8367111B2
(en)
*
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
MXPA04010956A
(es)
*
|
2003-01-30 |
2005-01-25 |
Roehm Gmbh |
Forma de dosis farmaceutica y metodo para la produccion de la misma.
|
MY162623A
(en)
*
|
2003-02-10 |
2017-06-30 |
Biogen Ma Inc |
Immunoglobulin formulation and method of preparation thereof
|
US7737133B2
(en)
|
2003-09-03 |
2010-06-15 |
Agi Therapeutics Ltd. |
Formulations and methods of treating inflammatory bowel disease
|
WO2005027877A1
(en)
|
2003-09-15 |
2005-03-31 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
PT2210605T
(pt)
|
2003-11-04 |
2017-04-24 |
Tcd Royalty Sub Llc |
Formas de dosagem única diária de tróspio
|
WO2005046663A1
(en)
|
2003-11-04 |
2005-05-26 |
Shire Laboratories, Inc. |
Compositions of quaternary ammonium containing bioavailability enhancers
|
US7470435B2
(en)
*
|
2003-11-17 |
2008-12-30 |
Andrx Pharmaceuticals, Llc |
Extended release venlafaxine formulation
|
AT500144A1
(de)
*
|
2004-03-05 |
2005-11-15 |
Sanochemia Pharmazeutika Ag |
Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
|
EP1768668A2
(en)
|
2004-06-16 |
2007-04-04 |
Tap Pharmaceutical Products, Inc. |
Multiple ppi dosage form
|
DE102004035936A1
(de)
*
|
2004-07-23 |
2006-03-16 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform
|
US8747895B2
(en)
*
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
CA2584957C
(en)
|
2004-10-21 |
2015-08-25 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
DE102005000719A1
(de)
*
|
2005-01-03 |
2006-07-20 |
Nextpharma Gmbh |
Pharmazeutische Zusammensetzung zur kontrollierten Freisetzung von ß-Lactam-Antibiotika in Kombination mit ß-Lactamase-Inhibitoren
|
US9149439B2
(en)
*
|
2005-03-21 |
2015-10-06 |
Sandoz Ag |
Multi-particulate, modified-release composition
|
CN101111230B
(zh)
*
|
2005-03-29 |
2010-05-19 |
赢创罗姆有限责任公司 |
包含对活性成分具有调节释放作用的小丸的多颗粒药用形式
|
KR20070119658A
(ko)
*
|
2005-03-29 |
2007-12-20 |
에보니크 룀 게엠베하 |
활성 성분 방출에 대한 조절 효과를 가지는 물질을포함하는 펠렛을 포함하는 다중 미립자 제약 형태
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
PT1883396E
(pt)
|
2005-05-18 |
2013-10-08 |
Centre Nat Rech Scient |
Administração colónica de adsorventes
|
CA2611938A1
(en)
*
|
2005-06-13 |
2007-01-25 |
Elan Corporation, Plc |
Modified release ticlopidine compositions
|
AU2006259224B2
(en)
|
2005-06-16 |
2012-08-23 |
Mohammed Saeed |
Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
|
CA2613107A1
(en)
*
|
2005-06-23 |
2007-01-04 |
Spherics, Inc. |
Delayed release or extended-delayed release dosage forms of pramipexole
|
US20070003621A1
(en)
*
|
2005-06-23 |
2007-01-04 |
Spherics, Inc. |
Dosage forms for movement disorder treatment
|
US8298565B2
(en)
|
2005-07-15 |
2012-10-30 |
Micell Technologies, Inc. |
Polymer coatings containing drug powder of controlled morphology
|
WO2007011708A2
(en)
|
2005-07-15 |
2007-01-25 |
Micell Technologies, Inc. |
Stent with polymer coating containing amorphous rapamycin
|
US8865197B2
(en)
*
|
2005-09-06 |
2014-10-21 |
Israel Oceanographic And Limnological Research Ltd. |
Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
|
BRPI0615860B8
(pt)
*
|
2005-09-09 |
2021-05-25 |
Labopharm Barbados Ltd |
composição farmacêutica de liberação prolongada monolítica sólida
|
US20070082046A1
(en)
*
|
2005-10-11 |
2007-04-12 |
Banner Pharmacaps, Inc. |
Enteric valproic acid
|
CA2638914C
(en)
|
2006-02-09 |
2014-04-08 |
Alba Therapeutics Corporation |
Formulations for a tight junction effector
|
PL2019657T3
(pl)
|
2006-04-26 |
2015-10-30 |
Micell Technologies Inc |
Powłoki zawierające wiele leków
|
US8048413B2
(en)
|
2006-05-17 |
2011-11-01 |
Helene Huguet |
Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
|
US20070292510A1
(en)
*
|
2006-06-19 |
2007-12-20 |
Hugh Huang |
Enteric coated particles containing an active ingredient
|
US20080131492A1
(en)
*
|
2006-06-23 |
2008-06-05 |
Spherics, Inc. |
Dosage forms for movement disorder treatment
|
US8636767B2
(en)
|
2006-10-02 |
2014-01-28 |
Micell Technologies, Inc. |
Surgical sutures having increased strength
|
UY30636A1
(es)
*
|
2006-10-18 |
2008-05-02 |
Senosiain Lab |
Composision farmaceutica de liberacon modificada de un musculo relajante y un aine
|
CN101678388B
(zh)
|
2006-10-23 |
2013-12-11 |
米歇尔技术公司 |
用于在涂覆过程中为基底充电的保持器
|
US8034776B2
(en)
|
2006-10-26 |
2011-10-11 |
Alba Therapeutics Corporation |
Materials and methods for the treatment of celiac disease
|
WO2008068778A2
(en)
*
|
2006-12-05 |
2008-06-12 |
Alembic Limited |
Extended release pharmaceutical composition of pramipexole
|
AU2007338631A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Combinatorx, Incorporated |
Pharmaceutical compositions for treatment of parkinson's disease and related disorders
|
CA2679712C
(en)
|
2007-01-08 |
2016-11-15 |
Micell Technologies, Inc. |
Stents having biodegradable layers
|
US11426494B2
(en)
|
2007-01-08 |
2022-08-30 |
MT Acquisition Holdings LLC |
Stents having biodegradable layers
|
BRPI0700133A
(pt)
*
|
2007-01-29 |
2008-09-16 |
Incrementha P D & I Pesquisa D |
composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
|
SI2120878T1
(sl)
*
|
2007-02-09 |
2014-12-31 |
Alphapharm Pty Ltd |
Dozirna oblika, ki vsebuje dve aktivni farmacevtski sestavini v različnih fizičnih oblikah
|
JP5452236B2
(ja)
*
|
2007-03-02 |
2014-03-26 |
ファーナム・カンパニーズ・インコーポレーテッド |
ロウ様物質を用いた徐放性組成物
|
US9433516B2
(en)
|
2007-04-17 |
2016-09-06 |
Micell Technologies, Inc. |
Stents having controlled elution
|
ES2759626T3
(es)
|
2007-05-07 |
2020-05-11 |
Evonik Operations Gmbh |
Formas farmacéuticas sólidas que comprenden un recubrimiento entérico con liberación acelerada del fármaco
|
EP2170418B1
(en)
*
|
2007-05-25 |
2016-03-16 |
Micell Technologies, Inc. |
Polymer films for medical device coating
|
US20110130822A1
(en)
*
|
2007-07-20 |
2011-06-02 |
Orbusneich Medical, Inc. |
Bioabsorbable Polymeric Compositions and Medical Devices
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
EP2200611A4
(en)
*
|
2007-09-14 |
2010-09-22 |
Biogen Idec Inc |
COMPOSITIONS AND METHODS FOR TREATING PROGRESSIVE MULTIFOCAL LEUCOENCEPHALEPATHY (PML)
|
KR20170097787A
(ko)
*
|
2007-10-12 |
2017-08-28 |
다케다 파마슈티칼스 유에스에이, 인코포레이티드 |
음식 섭취와 관계없이 위장 장애를 치료하는 방법
|
AR070863A1
(es)
*
|
2008-03-11 |
2010-05-12 |
Takeda Pharmaceutical |
Preparacion solida de desintegracion oral y metodo para suprimir la ruptura de los granulos finos durante la produccion de un comprimido
|
MX2010011485A
(es)
|
2008-04-17 |
2011-03-01 |
Micell Technologies Inc |
Stents que contienen capas bioadsorbibles.
|
AU2009270849B2
(en)
|
2008-07-17 |
2013-11-21 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US9510856B2
(en)
|
2008-07-17 |
2016-12-06 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US10668012B2
(en)
*
|
2008-09-04 |
2020-06-02 |
Farnam Companies, Inc. |
Chewable sustained release formulations
|
US20100068153A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo activatable final dosage form
|
US20100068235A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete LLC, a limited liability corporation of Deleware |
Individualizable dosage form
|
US20100068256A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo modifiable medicament release-substance
|
US20100068152A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo modifiable particle or polymeric based final dosage form
|
US20100069887A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Multiple chamber ex vivo adjustable-release final dosage form
|
US20100069821A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Ex vivo modifiable medicament release-sites final dosage form
|
US20100068233A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Modifiable dosage form
|
US20100068275A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Personalizable dosage form
|
DE102008048729A1
(de)
*
|
2008-09-24 |
2010-03-25 |
Add Technologies Ltd Advanced Drug Delivery |
Multipartikuläre Tabletten und Verfahren zur deren Herstellung
|
WO2010077908A1
(en)
*
|
2008-12-17 |
2010-07-08 |
Altheus Therapeutics, Inc. |
Oral formulations
|
US8834913B2
(en)
|
2008-12-26 |
2014-09-16 |
Battelle Memorial Institute |
Medical implants and methods of making medical implants
|
EP2411440B1
(en)
*
|
2009-03-23 |
2018-01-17 |
Micell Technologies, Inc. |
Improved biodegradable polymers
|
WO2010111232A2
(en)
|
2009-03-23 |
2010-09-30 |
Micell Technologies, Inc. |
Drug delivery medical device
|
JP2012522589A
(ja)
|
2009-04-01 |
2012-09-27 |
ミシェル テクノロジーズ,インコーポレイテッド |
被覆ステント
|
WO2010132707A1
(en)
*
|
2009-05-14 |
2010-11-18 |
Orbusneich Medical, Inc. |
Self-expanding stent with polygon transition zone
|
SG10201407965XA
(en)
|
2009-12-02 |
2015-02-27 |
Aptalis Pharma Ltd |
Fexofenadine microcapsules and compositions containing them
|
US8865213B2
(en)
*
|
2009-12-30 |
2014-10-21 |
Usv Limited |
Modified release pharmaceutical compositions
|
TW201127375A
(en)
*
|
2010-01-08 |
2011-08-16 |
Eurand Inc |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
EP2531140B1
(en)
|
2010-02-02 |
2017-11-01 |
Micell Technologies, Inc. |
Stent and stent delivery system with improved deliverability
|
EP2371356B1
(en)
|
2010-03-12 |
2012-12-19 |
Phoeme GmbH |
Multi-particle pharmaceutical formulation for colon absorption
|
US8795762B2
(en)
|
2010-03-26 |
2014-08-05 |
Battelle Memorial Institute |
System and method for enhanced electrostatic deposition and surface coatings
|
EP2560576B1
(en)
|
2010-04-22 |
2018-07-18 |
Micell Technologies, Inc. |
Stents and other devices having extracellular matrix coating
|
BR112012030641B8
(pt)
*
|
2010-06-01 |
2022-06-14 |
Geistlich Pharma Ag |
Usos e composições para terapia farmacêutica oral
|
AU2011268146A1
(en)
|
2010-06-17 |
2013-01-10 |
Actogenix Nv |
Compositions and methods for treating inflammatory conditions
|
EP2593039B1
(en)
|
2010-07-16 |
2022-11-30 |
Micell Technologies, Inc. |
Drug delivery medical device
|
HU230560B1
(hu)
*
|
2010-07-30 |
2016-12-28 |
Péter Hajnal |
pH-függő szakaszos és nyújtott hatóanyagleadású gyógyszerkészítmény
|
US20120164233A1
(en)
|
2010-07-30 |
2012-06-28 |
Ranbaxy Laboratories Limited |
Pulsatile release pharmaceutical formulation of dexlansoprazole
|
CA2823355C
(en)
|
2010-12-30 |
2017-08-22 |
Micell Technologies, Inc. |
Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore
|
EP2696815B1
(en)
|
2011-04-13 |
2019-03-20 |
Micell Technologies, Inc. |
Stents having controlled elution
|
WO2012166819A1
(en)
|
2011-05-31 |
2012-12-06 |
Micell Technologies, Inc. |
System and process for formation of a time-released, drug-eluting transferable coating
|
CA2841360A1
(en)
|
2011-07-15 |
2013-01-24 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US10188772B2
(en)
|
2011-10-18 |
2019-01-29 |
Micell Technologies, Inc. |
Drug delivery medical device
|
CN110269959A
(zh)
|
2013-03-12 |
2019-09-24 |
脉胜医疗技术公司 |
可生物吸收的生物医学植入物
|
JP6294457B2
(ja)
*
|
2013-03-15 |
2018-03-14 |
ワーナー チルコット カンパニー, エルエルシーWarner Chilcott Company, Llc |
低減した送達変動性のための複数の投薬要素を備えるメサラミン医薬組成物
|
CA2912387C
(en)
|
2013-05-15 |
2019-04-16 |
Micell Technologies, Inc. |
Bioabsorbable biomedical implants
|
US20170143743A1
(en)
*
|
2014-06-16 |
2017-05-25 |
Valpharma International S.P.A. |
Formulation for oral administration containing mesalazine
|
CA2936746C
(en)
|
2014-10-31 |
2017-06-27 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
EP3288556A4
(en)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
BR112017025148A2
(pt)
|
2015-06-05 |
2018-08-07 |
Evonik Röhm Gmbh |
composição farmacêutica ou nutracêutica com resistência contra a influência do etanol
|
CN105663091A
(zh)
*
|
2016-01-28 |
2016-06-15 |
上海信谊百路达药业有限公司 |
一种布地奈德肠溶缓释胶囊及其制备方法
|
US10792477B2
(en)
|
2016-02-08 |
2020-10-06 |
Orbusneich Medical Pte. Ltd. |
Drug eluting balloon
|
CN110201242A
(zh)
|
2016-02-08 |
2019-09-06 |
祥丰医疗私人有限公司 |
一种医疗装置
|
JP7021108B2
(ja)
*
|
2016-04-19 |
2022-02-16 |
コナリス リサーチ インスティテュート アクチェンゲゼルシャフト |
ニコチンアミドの経口薬学的組成物
|
RU2744576C2
(ru)
*
|
2016-04-19 |
2021-03-11 |
Ферринг Б.В. |
Пероральные фармацевтические композиции месалазина
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
US20180085498A1
(en)
|
2016-09-23 |
2018-03-29 |
Micell Technologies, Inc. |
Prolonged drug-eluting products
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
EP3862032A1
(en)
|
2020-02-07 |
2021-08-11 |
Micell Technologies, Inc. |
Stents having biodegradable layers
|
CN111759552A
(zh)
|
2020-07-06 |
2020-10-13 |
苏州莱诺医疗器械有限公司 |
一种可吸收支架系统
|